JPS56104814A - Preparation of eye drop - Google Patents

Preparation of eye drop

Info

Publication number
JPS56104814A
JPS56104814A JP797480A JP797480A JPS56104814A JP S56104814 A JPS56104814 A JP S56104814A JP 797480 A JP797480 A JP 797480A JP 797480 A JP797480 A JP 797480A JP S56104814 A JPS56104814 A JP S56104814A
Authority
JP
Japan
Prior art keywords
fatty acid
eye drop
polymeric
acid
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP797480A
Other languages
Japanese (ja)
Inventor
Kunihiro Okanoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP797480A priority Critical patent/JPS56104814A/en
Publication of JPS56104814A publication Critical patent/JPS56104814A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: To prepare eye drop having no side effect and effective for the remedy of eye diseases, by reacting olive oil as a base with isopropyl myristate to obtain a solubilized polymeric higher fatty acid, and emulsifying the polymeric fatty acid with an aqueous solution containing various chemicals.
CONSTITUTION: A solubilized polymeric higher fatty acid is prepared by mixing and stirring specific amounts of polyoxyethylene lauryl ether, polyoxyethylene hardened castor oil, and isopropyl myristate in 50ml of olive oil. Separately, specific amounts of neostigmine methyl sulfate, aminoethylsulfonic acid, zinc sulfate, and boric acid are dissolved in 30ml of distilled water, and the solubtion is mixed with the above polymeric fatty acid with stirring to obtain the objective eye drop. The eye drop gives untrition and moistness to the eyeball, and is effective to various eye diseases and asthenopia.
COPYRIGHT: (C)1981,JPO&Japio
JP797480A 1980-01-25 1980-01-25 Preparation of eye drop Pending JPS56104814A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP797480A JPS56104814A (en) 1980-01-25 1980-01-25 Preparation of eye drop

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP797480A JPS56104814A (en) 1980-01-25 1980-01-25 Preparation of eye drop

Publications (1)

Publication Number Publication Date
JPS56104814A true JPS56104814A (en) 1981-08-20

Family

ID=11680424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP797480A Pending JPS56104814A (en) 1980-01-25 1980-01-25 Preparation of eye drop

Country Status (1)

Country Link
JP (1) JPS56104814A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002122A1 (en) * 2000-07-03 2002-01-10 Unimed Pharma Spol. S.R.O. Ophthalmological drops with anti-imflammatory effect based on a wide-spectrum antibiotic and a local glucocorticoid
WO2010141648A3 (en) * 2009-06-05 2011-03-10 Allergan, Inc. Artificial tears and therapeutic uses
US10105386B2 (en) 2011-10-06 2018-10-23 Allergan, Inc. Compositions for the treatment of dry eye
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
US11389420B2 (en) 2017-07-25 2022-07-19 Das-Mg, Inc. Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis
US11896582B2 (en) 2017-01-09 2024-02-13 Das-Mg, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes
US12023315B2 (en) 2022-07-01 2024-07-02 Somerset Therapeutics, Llc Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002122A1 (en) * 2000-07-03 2002-01-10 Unimed Pharma Spol. S.R.O. Ophthalmological drops with anti-imflammatory effect based on a wide-spectrum antibiotic and a local glucocorticoid
WO2010141648A3 (en) * 2009-06-05 2011-03-10 Allergan, Inc. Artificial tears and therapeutic uses
AU2010256652B2 (en) * 2009-06-05 2015-11-26 Allergan, Inc. Artificial tears and therapeutic uses
US9821020B2 (en) 2009-06-05 2017-11-21 Allergan, Inc. Artificial tears and therapeutic uses
US11045515B2 (en) 2009-06-05 2021-06-29 Allergan, Inc. Artificial tears and therapeutic uses
US10105386B2 (en) 2011-10-06 2018-10-23 Allergan, Inc. Compositions for the treatment of dry eye
US10279005B2 (en) 2014-11-25 2019-05-07 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
US11896582B2 (en) 2017-01-09 2024-02-13 Das-Mg, Inc. Use and composition for treating myasthenia gravis and other myasthenic syndromes
US11389420B2 (en) 2017-07-25 2022-07-19 Das-Mg, Inc. Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis
US12023315B2 (en) 2022-07-01 2024-07-02 Somerset Therapeutics, Llc Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis

Similar Documents

Publication Publication Date Title
EP1002526B1 (en) Skin whitening composition containing bearberry extract and a reducing agent
DE3239184C2 (en) Shampoo for the treatment of the hair
ES2079336T1 (en) NEW SURFACE COMPOSITIONS, PROCEDURE FOR THE PREPARATION AND PESTICIDE COMPOSITIONS CONTAINING IT.
EP0079074A2 (en) Hair tonic composition
JPS56104814A (en) Preparation of eye drop
GB1372538A (en) Surface-active organoboron compounds
JPS61238719A (en) Hair cosmetic
EP0867176A3 (en) Shower preparations with a high oil content
ES2043891T3 (en) PROCEDURE FOR PREPARING NEW ANTIARRHYTHMIC AGENTS II.
EP0870495A3 (en) Cosmetic washing compositions based on emulsions which do not contain conventional emulsifiers
EP0111895A3 (en) Skin care emulsion
JPS5653608A (en) Emulsified stick cosmetic
JPS61263910A (en) Hair cosmetic
JPS577235A (en) Preparation of emulsion
FR2454761A1 (en) SYNERGISTIC FUNGICIDE COMPOSITION, METHOD FOR CONTROLLING DISEASES OF PLANTS DUE TO MUSHROOMS USING THE SAME AND PHARMACEUTICAL COMPOSITION CONTAINING THE ACTIVE INGREDIENT OF THIS COMPOSITION
JPS56125305A (en) Creamy or milky lotion cosmetic
DE2226927A1 (en) COMPOSITION AND ADMINISTRATION FORM EFFECTIVE AGAINST ADDICTION AND CELLULITIS
JP2549148B2 (en) Cleaning cosmetics
DE69429719T2 (en) Inclusion of a water-soluble active ingredient in a lipid
DE2725525A1 (en) COSMETIC PREPARATION
JPS5540644A (en) Agent against candidiasis
JPS57109713A (en) Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom
JPS56110611A (en) Preparation of ointment embrocation for skin
JPS5633029A (en) Preparation of oil in water type powder dispersed emulsification composite
JPS5762220A (en) Embrocation for external use